Ep13: The New Breed of DTx May Not Be a DTx At All
Ask Chris Bergstrom what gets him out of bed in the morning, and he says very simply: “scale, scale, scale.” Chris brings a powerful blend of experience in start-ups, large companies, and the life sciences to his role as president of Amalgam Rx, a digital platform that brings providers and life sciences companies together to grow digital health solutions. Chris and Eugene talk about Amalgam’s origins and capabilities, and in response to a question from Brian Dolan about Amalgam’s recent acquisition of Avhana Health, Chris reveals that Amalgam has been lucky enough to start off as a fully self-funded venture. Finally, listen in as Chris and Eugene discuss whether the term “digital therapeutic” has become passé. >>Click here to read the transcript Guest Links and Resources: Connect with Chris Bergstrom: LinkedIn Visit Amalgam Rx: LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche